Stock 688319 CHENGDU OLYMVAX BIOPHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Chengdu Olymvax Biopharmaceuticals Inc.

Equities

688319

CNE1000051H8

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-05-30 pm EDT 		5-day change 1st Jan Change
9.69 CNY -0.41% Intraday chart for Chengdu Olymvax Biopharmaceuticals Inc. +19.48% -38.67%
May. 16 Olymvax Biopharma's Flu Vaccine Gets China Nod for Clinical Trials MT
Apr. 25 Chengdu Olymvax Biopharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Business Summary

Chengdu Olymvax Biopharmaceuticals Inc is a China-based biopharmaceutical company mainly engaged in the research, development, production and sales of human vaccines. The Company's products mainly include adsorbed tetanus vaccine, Hib conjugate vaccine and tetanus toxoid concentrate stock solution. The Company's main customers are center for disease control and prevention (CDC) customers.

Number of employees: 471

Sales per Business

CNY in Million2022Weight2023Weight Delta
Adsorbed Tetanus Vaccine
93.3 %
438 79.9 % 463 93.3 % +5.78%
Haemophilus Influenzae Type B Conjugate Vaccine
5.5 %
55 10.0 % 27 5.5 % -50.10%
Group A and Group C Meningococcal Polysaccharide Conjugate Vaccine
0.8 %
54 9.9 % 4 0.8 % -92.85%
Other
0.4 %
1 0.1 % 2 0.4 % +127.76%
Refined Tetanus Toxoid Stock Solution
0.0 %
0 0.0 % 0 0.0 % +83.33%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
100.0 %
547 100.0 % 496 100.0 % -9.38%

Managers

Managers TitleAgeSince
Shao Wen Fan CEO
 Chief Executive Officer 71 09-12-31
Yong Tan DFI
 Director of Finance/CFO 50 09-12-08
Qiang Wu CTO
 Chief Tech/Sci/R&D Officer 48 10-12-31
Tian Jun Cheng BRD
 Director/Board Member 34 12-12-31
Ai Min Chen BRD
 Director/Board Member 69 08-12-31
Cheng Hu BRD
 Director/Board Member 57 12-12-31
Fan Fan BRD
 Director/Board Member 43 09-12-31
Wei Wu SEC
 Corporate Secretary 42 09-12-08

Members of the board

Members of the board TitleAgeSince
Yun Hui Yu BRD
 Director/Board Member 61 13-05-31
Shao Wen Fan CEO
 Chief Executive Officer 71 09-12-31
Fan Fan BRD
 Director/Board Member 43 09-12-31
Cheng Hu BRD
 Director/Board Member 57 12-12-31
Ai Min Chen BRD
 Director/Board Member 69 08-12-31
Lu Lu BRD
 Director/Board Member 68 22-05-17
Xian Chun Li BRD
 Director/Board Member 57 19-04-23
Peng Fei Zhang CHM
 Chairman 39 16-05-31
Tian Jun Cheng BRD
 Director/Board Member 34 12-12-31
Hua Yan BRD
 Director/Board Member 59 22-05-17

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 406,158,300 187,474,099 ( 46.16 %) 749,000 ( 0.1844 %) 46.16 %

Shareholders

NameEquities%Valuation
Peng Fei Zhang
8.984 %
25,893,040 8.984 % 33 M ¥
GF Fund Management Co., Ltd.
6.001 %
17,295,256 6.001 % 22 M ¥
Yu Zhang
5.364 %
15,460,000 5.364 % 19 M ¥
Orient Securities Asset Management Co. Ltd.
0.9089 %
2,619,621 0.9089 % 3 M ¥
Fullgoal Fund Management Co., Ltd.
0.8872 %
2,557,116 0.8872 % 3 M ¥
Bank of Communications Schroder Fund Management Co., Ltd.
0.2268 %
653,720 0.2268 % 821 497 ¥
UBS SDIC Fund Management Co., Ltd.
0.2036 %
586,823 0.2036 % 737 431 ¥
Hongde Fund Management Co., Ltd.
0.1912 %
551,124 0.1912 % 692 570 ¥
Zhong Ou Asset Management Co., Ltd
0.1623 %
467,714 0.1623 % 587 753 ¥
Truvalue Asset Management Co. Ltd.
0.1422 %
409,878 0.1422 % 515 073 ¥

Company contact information

Chengdu Olymvax Biopharmaceuticals, Inc.

99 Tianxin Road High-Tech Zone

611731, Chengdu

+

http://www.olymvax.com
address Chengdu Olymvax Biopharmaceuticals Inc.(688319)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Sales per Business

Ratings for Chengdu Olymvax Biopharmaceuticals Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
9.69
Average target price
-
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Biopharmaceuticals

1st Jan change Capi.
CHENGDU OLYMVAX BIOPHARMACEUTICALS INC. Stock Chengdu Olymvax Biopharmaceuticals Inc.
-38.67% 543M
CSL LIMITED Stock CSL Limited
-2.29% 89.87B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
-3.95% 37.57B
BIOGEN INC. Stock Biogen Inc.
-13.07% 32.75B
UCB Stock UCB
+63.05% 26.47B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-22.14% 14.25B
INCYTE CORPORATION Stock Incyte Corporation
-7.96% 12.99B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-9.33% 11.93B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-46.33% 10.84B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+5.77% 9.11B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. 688319 Stock
  4. Company Chengdu Olymvax Biopharmaceuticals Inc.